Drug reduces deaths for subset of COVID-19 patients in trial
Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
16 June 2021Covid-19: Extended emergency and Olympic concerns overshadow Japan’s accelerated vaccine rollout
16 June 2021Drug reduces deaths for subset of COVID-19 patients in trial
Preliminary RECOVERY trial results find a monoclonal antibody (MAB) drug by Regeneron reduces the risk of death in a subset of patients with severe COVID-19.
